PeLeMed
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $6M
Investors
- 6
About PeLeMed
Founded in 2019 and based in Gwangju, South Korea, PeLeMed is a drug research and development company on cancer, nerve, immune diseases, and new drug development.S. Phase I trial, and to accelerate research and development of additional oncology pipeline assets.
Who invested in PeLeMed
6 investors across 1 round
See all investors in PeLeMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 8, 2020
Amount
$6M
Investors
Questions about PeLeMed
Who invested in PeLeMed?
PeLeMed has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PeLeMed raised?
PeLeMed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PeLeMed last raise money?
PeLeMed's most recent round on record is a Series A, in Dec 2020.
What does PeLeMed do?
Founded in 2019 and based in Gwangju, South Korea, PeLeMed is a drug research and development company on cancer, nerve, immune diseases, and new drug development.
Where is PeLeMed headquartered?
PeLeMed is headquartered in Gwangju, South Korea.
Which VCs invest in companies like PeLeMed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PeLeMed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PeLeMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.